368 Mrv0541 02231214382 d 12 12 0 0 1 0 999 V2000型2.8075 1.4438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.0930 -1.4438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.5220 -2.2688 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 4.2365 2.2688 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 3.5220 1.0313 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 3.5220 0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2365 1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8075 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2365 -0.2063 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.8075 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 4.2365 -1.0313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 3.5220 -1.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5 1 1 1 0 0 0 2 12 10 1 0 0 0 0 3 1 0 0 0 0 4 7 1 0 0 0 0 5 6 1 0 0 0 0 2 5 7 1 0 0 0 0 6 8 0 0 0 0 6 9 1 0 0 0 0 8 10 1 0 0 0 0 9 11 2 0 0 0 0 10 12 2 0 0 0 0 11 12 1 0 0 0 0 M >结束
DB00368 >
drugbank >
数控(C@H) (O) C1 = CC (O) = C (O) C = C >
InChI = 1 s / C8H11NO3 c9-4-8 (12) 5-1-2-6 (10) 7 (11) 3 - 5 / h1-3, 8日10-12H, 4、9 h2 / t8 - / mo / s1 >
SFLSHLFXELFNJZ-QMMMGPOBSA-N >
C8H11NO3 >
169.1778 >
169.073893223 >
4 >
23日>
0.9804874329635772 >
16.95880867290888 >
1 >
4 >
0 >
0 >
4 - [(1 r) 2-amino-1-hydroxyethyl] benzene-1,可>
-1.40 >
-0.6835133951859954 >
-1.13 >
0 >
1 >
1 >
1 >
12.65275638508942 >
9.500884650011601 >
8.84847263942599 >
86.71 >
44.4557 >
2 >
1 >
1.25 e + 1 g / l >
四氢叶酸>
0 >
DB00368 >
APRD01299 >
批准>
去甲肾上腺素>
(−)-arterenol;(−)去甲肾上腺素;(−)去甲肾上腺素;(R) -(−)去甲肾上腺素;(R) 4 - (2-amino-1-hydroxyethyl) 1, 2-benzenediol;(R)去甲肾上腺素;(R)去甲肾上腺素;4 - [(1 r) 2-amino-1-hydroxyethyl] 1, 2-benzenediol;Arterenol;L-noradrenaline; L-Norepinephrine; Nor-adrenaline; Noradrenaline; Norepinefrina; Norepinephrine; Norépinéphrine; Norepinephrinum >
Levophed;第四Levophed液体1.0毫克/毫升;Levophed (r)去甲肾上腺素酒石酸氢盐;去甲肾上腺素;去甲肾上腺素酒石酸氢盐;去甲肾上腺素酒石酸氢盐在5%葡萄糖注射液;去甲肾上腺素酒石酸氢盐Inj 1毫克/毫升USP;注射去甲肾上腺素酒石酸氢盐;注射去甲肾上腺素酒石酸氢盐USP;注射去甲肾上腺素酒石酸氢盐,USP; Norepinephrine bitartrate >
去甲肾上腺素酒石酸氢盐$ $ $ $